Distribution Agreement with GE Healthcare

Mediwatch plc enters into a distribution agreement with GE Healthcare


Mediwatch plc ("Mediwatch" or "the Company") (AIM: MDW), the innovative urological diagnostic manufacturing company, has entered into an agreement with GE Healthcare to distribute its ultrasound devices to selected areas in the US.

Under the terms of the agreement, Mediwatch will distribute GE Healthcare's ultrasound products for urology, nephrology, uro-gynecology and radiation oncology (urologic applications) practices.

"Mediwatch is proud to have the opportunity to market GE Healthcare's leading ultrasound technology in the US with our innovative range of products," said Philip Stimpson, Chief Executive Officer of Mediwatch. "The addition of GE Healthcare's ultrasound products will enhance our ability to offer a single source solution for urology healthcare providers."

Mediwatch plc enters into a distribution agreement with GE Healthcare



About Mediwatch plc:

Mediwatch is a leader in its field. The Company is continually striving to develop and market faster, simpler and less invasive diagnostic products to help save lives and restore quality of life for people with a variety of urological conditions. Founded in 1995, Mediwatch (www.mediwatch.com) has developed a range of point-of-care medical equipment for the diagnosis of urological disorders.

The business focuses its design skills towards diagnostic products that can be used across the medical profession.

Mediwatch has established excellent foundations for continued growth building on the acquisition and integration of a division of Medtronic Inc in 2007, an international distribution network and its research and development programmes.

Mediwatch has a global presence with offices in both the UK and US. The UK office is the base for manufacturing, research and development, sales and marketing to the rest of the world outside of the US and Canada with a direct sales force for the UK markets. The US office manages a direct sales and marketing infrastructure to cover the US and Canada along with some research and development activities.



About GE Healthcare:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $16 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.



For our latest news, please visit http://newsroom.gehealthcare.com

Distribution Agreement with GE Healthcare